Effect of epidural analgesia in trial of labor after cesarean on maternal and neonatal outcomes in China: a multicenter, prospective cohort study

BMC Pregnancy Childbirth. 2019 Dec 16;19(1):498. doi: 10.1186/s12884-019-2648-1.

Abstract

Background: The trial of labor after cesarean section (TOLAC) is a relatively new technique in mainland of China, and epidural analgesia is one of the risk factors for uterine rupture. This study aimed to evaluate the effect of epidural analgesia on primary labor outcome [success rate of vaginal birth after cesarean (VBAC)], parturient complications and neonatal outcomes after TOLAC in Chinese multiparas based on a strictly uniform TOLAC indication, management and epidural protocol.

Methods: A total of 423 multiparas undergoing TOLAC were enrolled in this study from January 2017 to February 2018. Multiparas were divided into two groups according to whether they received epidural analgesia (study group, N = 263) or not (control group, N = 160) during labor. Maternal delivery outcomes and neonatal characteristics were recorded and evaluated using univariate analysis, multivariable logistic regression and propensity score matching (PSM).

Results: The success rate of VBAC was remarkably higher (85.55% vs. 69.38%, p < 0.01) in study group. Epidural analgesia significantly shortened initiating lactation period and declined Visual Analogue Score (VAS). It also showed more superiority in neonatal umbilical arterial blood pH value. After matching by PSM, multivariable logistic regression revealed that the correction of confounding factors including epidural analgesia, cervical Bishop score at admission and spontaneous onset of labor were still shown as promotion probability in study group (OR = 4.480, 1.360, and 10.188, respectively; 95%CI = 2.025-10.660, 1.113-1.673, and 2.875-48.418, respectively; p < 0.001, p = 0.003, and p < 0.001, respectively).

Conclusions: Epidural analgesia could reduce labor pain, and no increased risk of postpartum bleeding or uterine rupture, as well as adverse effects in newborns were observed. The labor duration of multiparas was increased, but within acceptable range. In summary, epidural analgesia may be safe for both mother and neonate in the three studied hospitals.

Trial registration: Chineses Clinical Trial Register, ChiCTR-ONC-17010654. Registered February 16th, 2017.

Keywords: Epidural analgesia; Maternal and neonatal outcomes; Propensity score matching; Trial of labor after cesarean; Vaginal birth after cesarean.

Publication types

  • Multicenter Study

MeSH terms

  • Adult
  • Analgesia, Epidural / adverse effects*
  • Analgesia, Obstetrical / adverse effects*
  • China / epidemiology
  • Female
  • Humans
  • Infant, Newborn
  • Labor Pain / drug therapy*
  • Logistic Models
  • Obstetric Labor Complications / chemically induced
  • Obstetric Labor Complications / epidemiology*
  • Postpartum Hemorrhage / chemically induced
  • Postpartum Hemorrhage / epidemiology
  • Pregnancy
  • Pregnancy Outcome
  • Prospective Studies
  • Risk Factors
  • Trial of Labor*
  • Uterine Rupture / chemically induced
  • Uterine Rupture / epidemiology